Story

Our principal aim is to commission and fund high-quality scientific (biomedical) investigation into the causes, consequences and treatment of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), a debilitating illness which affects between 0.2 and 0.4% of the population.